GSK (GLAXF) Price-to-Owner-Earnings

: 11.95 (As of Today)

View and export this data going back to . Start your Free Trial

As of today (2024-04-16), GSK's share price is $20.20. GSK's Owner Earnings per Share (TTM) ended in Dec. 2023 was $1.69. It's Price-to-Owner-Earnings for today is 11.95.

The historical rank and industry rank for GSK's Price-to-Owner-Earnings or its related term are showing as below:

GLAXF' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 3.14 Med: 9.82 Max: 33.27
Current: 11.96

During the past 13 years, the highest Price-to-Owner-Earnings of GSK was 33.27. The lowest was 3.14. And the median was 9.82.

GLAXF's Price-to-Owner-Earnings is ranked better than
81.9% of 420 companies
in the Drug Manufacturers industry
Industry Median: 26.715 vs GLAXF: 11.96

As of today (2024-04-16), GSK's share price is $20.20. GSK's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $1.39. Therefore, GSK's PE Ratio for today is 14.50.

As of today (2024-04-16), GSK's share price is $20.20. GSK's EPS without NRI for the trailing twelve months (TTM) ended in was $1.53. Therefore, GSK's PE Ratio without NRI for today is 13.23.

During the past 13 years, GSK's highest PE Ratio without NRI was 33.71. The lowest was 5.50. And the median was 13.80.

GSK Price-to-Owner-Earnings Historical Data

The historical data trend for GSK's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GSK Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Owner-Earnings

11.17

6.59

11.31

3.61

10.48

GSK Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Price-to-Owner-Earnings																3.61	3.71	5.12	12.87	10.48

Competitive Comparison

For the Drug Manufacturers - General subindustry, GSK's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GSK Price-to-Owner-Earnings Distribution

For the Drug Manufacturers industry and Healthcare sector, GSK's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where GSK's Price-to-Owner-Earnings falls into.

GSK Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

GSK's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings	=	Share Price	/	Owner Earnings per Share (TTM)
	=	20.20	/	1.69
	=	11.95

GSK (OTCPK:GLAXF) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.

GSK Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of GSK's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.

GSK (GLAXF) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GSK PLC (OTCPK:GLAXF) » Definitions » Price-to-Owner-Earnings

Comparable Companies

Traded in Other Exchanges

GSK:USA GSK N:Mexico GSKl:UK GSK:UK GS71:Germany GS70:Germany GS71:Germany GS70:Germany GS71:Germany G1SK34:Brazil GSK:Argentina

Address

980 Great West Road, Brentford, Middlesex, GBR, TW8 9GS

Website

https://www.gsk.com

In the pharmaceutical industry, GSK ranks as one of the largest companies by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.